Configurable Digital Virus Counter on Robust Universal DNA Chips.

Autor: Seymour E; Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States., Ünlü NL; Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States., Carter EP; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02218, United States., Connor JH; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02218, United States., Ünlü MS; Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.; Department of Electrical and Computer Engineering, Boston University, Boston, Massachusetts 02215, United States.
Jazyk: angličtina
Zdroj: ACS sensors [ACS Sens] 2021 Jan 22; Vol. 6 (1), pp. 229-237. Date of Electronic Publication: 2021 Jan 11.
DOI: 10.1021/acssensors.0c02203
Abstrakt: Here, we demonstrate real-time multiplexed virus detection by applying a DNA-directed antibody immobilization technique in a single-particle interferometric reflectance imaging sensor (SP-IRIS). In this technique, the biosensor chip surface spotted with different DNA sequences is converted to a multiplexed antibody array by flowing antibody-DNA conjugates and allowing for specific DNA-DNA hybridization. The resulting antibody array is shown to detect three different recombinant vesicular stomatitis viruses (rVSVs), which are genetically engineered to express surface glycoproteins of Ebola, Marburg, and Lassa viruses in real time in a disposable microfluidic cartridge. We also show that this method can be modified to produce a single-step, homogeneous assay format by mixing the antibody-DNA conjugates with the virus sample in the solution phase prior to incubation in the microfluidic cartridge, eliminating the antibody immobilization step. This homogenous approach achieved detection of the model Ebola virus, rVSV-EBOV, at a concentration of 100 PFU/mL in 1 h. Finally, we demonstrate the feasibility of this homogeneous technique as a rapid test using a passive microfluidic cartridge. A concentration of 10 4 PFU/mL was detectable under 10 min for the rVSV-Ebola virus. Utilizing DNA microarrays for antibody-based diagnostics is an alternative approach to antibody microarrays and offers advantages such as configurable sensor surface, long-term storage ability, and decreased antibody use. We believe that these properties will make SP-IRIS a versatile and robust platform for point-of-care diagnostics applications.
Databáze: MEDLINE